Nizhegorodskaya Regional Clinical Hospital n.a. Semashko

Nizhny Novgorod 603126

0 studies enrolling now · 6 studies all time

What they study most

Crohn's Disease, Follicular Lymphoma, Ulcerative Colitis

Studies at this site

• Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma — Completed
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) — Completed
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis — Completed
• Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) — Completed
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis — Stopped early
• Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) — Completed